Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chauhan

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|July 6, 2000
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cellsD Chauhan, P Pandey, T Hideshima, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 26, 2009
Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosisJulien Gonzalez, Julie Klein, Sharmila D Chauhan, et al.
Indian Journal of Experimental Biology|June 1, 1997
Bioactivity of marine organisms: Part VIII--Screening of some marine flora of western coast of IndiaA K Siddhanta, K H Mody, B K Ramavat, et al.
Blood|February 9, 1999
Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasoneS P Treon, J A Mollick, M Urashima, et al.
Blood|July 15, 1997
The development of a model for the homing of multiple myeloma cells to human bone marrowM Urashima, B P Chen, S Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|November 20, 2024
Lorlatinib-associated weight gain and dyslipidaemia: A retrospective analysis and implications for future careA John, D J McMahon, D Chauhan, et al.
Blood|December 9, 1998
Adenovirus vector-based purging of multiple myeloma cellsG Teoh, L Chen, M Urashima, et al.
Blood|October 26, 2000
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapyT Hideshima, D Chauhan, Y Shima, et al.
Blood|July 4, 2001
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migrationK Podar, Y T Tai, F E Davies, et al.
Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|July 6, 2000
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cellsD Chauhan, P Pandey, T Hideshima, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 26, 2009
Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosisJulien Gonzalez, Julie Klein, Sharmila D Chauhan, et al.
Indian Journal of Experimental Biology|June 1, 1997
Bioactivity of marine organisms: Part VIII--Screening of some marine flora of western coast of IndiaA K Siddhanta, K H Mody, B K Ramavat, et al.
Blood|February 9, 1999
Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasoneS P Treon, J A Mollick, M Urashima, et al.
Blood|July 15, 1997
The development of a model for the homing of multiple myeloma cells to human bone marrowM Urashima, B P Chen, S Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|November 20, 2024
Lorlatinib-associated weight gain and dyslipidaemia: A retrospective analysis and implications for future careA John, D J McMahon, D Chauhan, et al.
Blood|December 9, 1998
Adenovirus vector-based purging of multiple myeloma cellsG Teoh, L Chen, M Urashima, et al.
Blood|October 26, 2000
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapyT Hideshima, D Chauhan, Y Shima, et al.
Blood|July 4, 2001
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migrationK Podar, Y T Tai, F E Davies, et al.
Leukemia|February 3, 2007
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathwayH Yasui, T Hideshima, H Ikeda, et al.
Pageof 15